Brief: Supriya Lifescience Gets Approval From Brazil's Anvisa For Esketamine Hydrochloride
09/12/2024 09:22
Dec 9 (Reuters) - Supriya Lifescience Ltd SPRL.NS :
* SUPRIYA LIFESCIENCE LTD - GETS APPROVAL FROM BRAZIL'S
ANVISA
FOR ESKETAMINE HYDROCHLORIDE
* SUPRIYA LIFESCIENCE - DEVELOPED TECHNIQUE FOR LOW-COST
MANUFACTURING OF ATORVASTATIN
Source text: ID:nBSE3X3Dp5
Further company coverage: SPRL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Supriya Lifescience
See all newsBrief: Supriya Lifescience Says Court Orders Provisional Release Of 200 KG Ketamine Hydrochloride Consignment
Brief: Supriya Lifescience Limited Says June-Quarter Profit 240.4 Million Rupees
India's Supriya Lifescience on track for worst fall in a month on probe into official
Brief: Supriya Lifescience Says Lote Facility Receives USFDA EIR With Voluntary Action Indicated Classification
India's Supriya Lifescience rises on higher quarterly profit